Evidence map›Paper›PMID 35889520›Full record

ArticleMolecules (Basel, Switzerland)2022

Screening and Research on Skin Barrier Damage Protective Efficacy of Different Mannosylerythritol Lipids.

Chenxu Jing, Jiling Guo, Zhenzhuo Li, Xiaohao Xu, Jing Wang, Lu Zhai, Jianzeng Liu, Guang Sun, Fei Wang, Yangfen Xu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. TotalInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Chenxu JingResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Jiling GuoJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China.
Zhenzhuo LiResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Xiaohao XuResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Jing WangResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Lu ZhaiResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Jianzeng LiuJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China.
Guang SunResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Fei WangResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Yangfen XuModern Hanfang Technology Company Limited, Guangzhou 510550, China.
Zhaolian LiModern Hanfang Technology Company Limited, Guangzhou 510550, China.
Daqing ZhaoJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China.
Rui JiangResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.
Liwei SunResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China.ORCID 0000-0003-4194-1889
The Affiliated Hospital to Changchun University of Chinese Medicine · CNChangchun University of Chinese Medicine · CN

Funding

Science and Technology Development Plan of Jilin Province 20210304002YYSynthetic Biotechnology Innovation Capacity Promotion Action Project of Tianjin E1M0220101Traditional Chinese Medicine Science and Technology Project of Jilin Province 2021141
6 · The paper itself

Abstract

Mannosylerythritol lipids (MELs) may prevent skin barrier damage, although their protective mechanisms and active monomeric constituents remain unclear. Here, three MELs were extracted from

Indexed as

UstilaginalesCells, CulturedGlycolipidsHumansSkinSodium Dodecyl SulfateSurface-Active AgentsGlycolipidsSodium Dodecyl SulfateSurface-Active AgentsFLGHaCaT cellsLORMEL-Bskin barrier damage

Identifiers

PMID35889520
PMCPMC9320248
OpenAlexW4286610782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.